{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-033704","form_type":"8-K","ticker":"NUVL","cik":"0001861560","company_name":"Nuvalent, Inc.","filed_at":"2022-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.819813+00:00","generated_at":"2026-06-23T05:11:08.832955+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Nuvalent elects Dr. Michael L. Meyers to the Board as Class II director","bullets":["Dr. Meyers was elected independent Class II director effective October 4, 2022.","He will also serve on the Nominating and Corporate Governance Committee.","Received initial option grant for 40,000 shares at $19.48 per share, vesting monthly over 3 years.","Compensation follows Nuvalent's non-employee director policy including annual cash retainers and equity.","No family relationships or transactions with the Company requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-033704","json":"https://secwatch.observer/filing/0001564590-22-033704.json","markdown":"https://secwatch.observer/filing/0001564590-22-033704.md","text":"https://secwatch.observer/filing/0001564590-22-033704.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/0001564590-22-033704-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/nuvl-8k_20221004.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:11:08.832955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39b18411c2","claim":"Michael L. Meyers was elected as Director at Nuvalent, Inc..","evidence_excerpt":"On October 4, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”) of the Board of Directors (the “Board”) of Nuvalent, Inc. (the “Company”), the Board elected Michael L. Meyers, M.D., Ph.D., as a member of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861560/000156459022033704/0001564590-22-033704-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}